In The News Posted September 2, 2020 Share Posted September 2, 2020 COVID-19 - La Agencia Nacional de Vigilancia Sanitaria (ANVISA) de Brasil autoriza el REPAVID-19 de Dompé, un ensayo clínico de fase 2 para el tratamiento de pacientes graves Diez centros brasileños en São Paulo, Brasilia, Presidente Prudente, Sao José do Rio Preto, Varginha, Salvador de...View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.